| Literature DB >> 16943651 |
JoAnne E Natale1, Jill G Joseph, Robert K Pretzlaff, Tomas J Silber, Anne-Marie Guerguerian.
Abstract
In order to optimize pediatric traumatic brain injury translational and clinical research, scientific and ethical challenges need to be recognized and addressed. Having recently conducted a multisite phase II safety/feasibility trial of magnesium sulfate as a neuroprotective agent, we supplement our own experience by a mini review of similar studies, identifying challenges and possible responses from the perspective of families, investigators, funding agencies and society. Copyright (c) 2006 S. Karger AG, Basel.Entities:
Mesh:
Year: 2006 PMID: 16943651 DOI: 10.1159/000094154
Source DB: PubMed Journal: Dev Neurosci ISSN: 0378-5866 Impact factor: 2.984